Skip to main content
Premium Trial:

Request an Annual Quote

SeqLL, FBI Partner to Develop Sequencing-Based Forensic Technology

NEW YORK — Sequencing instrument and services firm SeqLL said on Tuesday that it has signed a Cooperative Research and Development Agreement (CRADA) with the US Federal Bureau of Investigation to determine the forensic capabilities of SeqLL's RNA sequencing technology.

Under the terms of the two-year CRADA, the FBI's laboratory division and SeqLL will work together to develop an assay for forensic body fluid identification using the company's True Single Molecule Sequencing platform.

Financial and other terms of the arrangement were not disclosed.

"We appreciate the opportunity this CRADA provides, to methodically develop forensic applications utilizing SeqLL's technology," SeqLL Founder and CEO Daniel Jones said in a statement. "We look forward to demonstrating how single-molecule, PCR-free approaches are ideally suited for this space."

The Scan

International Team Proposes Checklist for Returning Genomic Research Results

Researchers in the European Journal of Human Genetics present a checklist to guide the return of genomic research results to study participants.

Study Presents New Insights Into How Cancer Cells Overcome Telomere Shortening

Researchers report in Nucleic Acids Research that ATRX-deficient cancer cells have increased activity of the alternative lengthening of telomeres pathway.

Researchers Link Telomere Length With Alzheimer's Disease

Within UK Biobank participants, longer leukocyte telomere length is associated with a reduced risk of dementia, according to a new study in PLOS One.

Nucleotide Base Detected on Near-Earth Asteroid

Among other intriguing compounds, researchers find the nucleotide uracil, a component of RNA sequences, in samples collected from the near-Earth asteroid Ryugu, as they report in Nature Communications.